BioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest Update

BioStem Technologies, Inc. (OTCMKTS:BSEM) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 37,400 shares, an increase of 152.7% from the March 31st total of 14,800 shares. Based on an average daily volume of 68,700 shares, the short-interest ratio is presently 0.5 days.

BioStem Technologies Stock Performance

Shares of BSEM stock traded down 0.30 during midday trading on Friday, reaching 9.11. 19,900 shares of the stock were exchanged, compared to its average volume of 32,388. BioStem Technologies has a 1 year low of 1.20 and a 1 year high of 15.50. The company has a 50 day simple moving average of 10.38.

BioStem Technologies (OTCMKTS:BSEM) last issued its earnings results on Monday, April 1st. The company reported -0.14 earnings per share (EPS) for the quarter. The firm had revenue of 11.44 million during the quarter, compared to analysts’ expectations of 11.40 million. Sell-side analysts forecast that BioStem Technologies will post 3.14 earnings per share for the current year.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.